Flulaval 2025/2026 19515-0904
Generic: Influenza Virus Vaccine
Product NDC
19515-0904- Manufacturer
- Id Biomedical Corporation Of Quebec
- Dosage Form
- Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 1, 2025
- Application
- BLA125163
Active Ingredients
| Ingredient | Strength |
|---|---|
| Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (uv, Formaldehyde Inactivated) | 15 ug/.5mL |
| Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (uv, Formaldehyde Inactivated) | 15 ug/.5mL |
| Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (uv, Formaldehyde Inactivated) | 15 ug/.5mL |
Packaging Options(1)
10 SYRINGE in 1 CARTON (19515-904-52) / .5 mL in 1 SYRINGE (19515-904-41)